STUELPNAGEL JOHN R 4
4 · 10x Genomics, Inc. · Filed Jan 4, 2022
Insider Transaction Report
Form 4
STUELPNAGEL JOHN R
Director
Transactions
- Sale
Class A Common Stock
2021-12-30$150.56/sh−3,218$484,501→ 343,398 total - Sale
Class A Common Stock
2021-12-30$151.56/sh−1,782$270,089→ 341,616 total
Footnotes (3)
- [F1]The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- [F2]This transaction was executed in multiple trades at prices ranging from $150.00 to $150.98. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F3]This transaction was executed in multiple trades at prices ranging from $151.02 to $151.98. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.